Pharmaceutical care program for patients with chronic kidney disease in the community pharmacy: Detection of nephrotoxic drugs and dose adjustment. Viability study

• Gema Escribá-Martí,

  Roles Conceptualization, Data curation, Investigation, Methodology

  Affiliation Community Pharmacist in Segart, Valencia, Spain

  ⨯
• Iker Cámara-Ramos,

  Roles Conceptualization, Investigation

  Affiliation Community Pharmacist in Bilbao, Bilbao, Spain

  https://orcid.org/0000-0002-4292-2236

  ⨯
• María Teresa Climent-Catalá,

  Roles Conceptualization, Investigation

  Affiliation Doctor of Pharmacy, President of the SEFAC Delegation in the Valencian Community, Community Pharmacist in L’Olleria, Valencia, Spain

  ⨯
• Verónica Escudero-Quesada,

  Roles Methodology, Validation

  Affiliation Nephrologist, Nephrology Service, Dr. Peset University Hospital, Valencia, Spain

  https://orcid.org/0000-0002-2735-1535

  ⨯
• Luis Salar-Ibáñez

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Supervision, Validation, Writing – original draft, Writing – review & editing

  * E-mail: l.salar.000@micof.es

  Affiliation Doctor of Pharmacy, Cardenal Herrera University–CEU, Community Pharmacist in Valencia, Valencia, Spain

  https://orcid.org/0000-0001-9142-0569

  ⨯